Please reload

Recent Posts

Virtuvax for collaboration on your innovation in vaccine development or your biosimilar

May 12, 2017

1/2
Please reload

Featured Posts

Virtuvax to attend DCVMN in Kunming

September 19, 2018

Virtuvax consults in vaccine development and provides biosimilar and vaccine technologies. A most recent one, is the prefusion RSV-F vaccine technology. If you are interested, I would be most interested to meet you at the developing countries vaccine manufacturers network (DCVMN) annual meeting in Kunming, China, from October 29 - 31 2018.  

 

 

Tags: vaccine development, disruptive technology, biosimilar, monoclonal antibody, vaccine technology, DCVMN, Kunming, vaccine consultancy, RSV, pre-fusion RSV-F, RSV vaccine, pneumococcal vaccine

 

 

 

 

Please reload

Follow Us
Search By Tags